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Bovine tuberculosis (bTB) challenges intensive dairy production in Ethiopia and imple-
mentation of the test and slaughter control strategy is not economically acceptable
in the country. Vaccination of cattle with Bacillus Calmette–Guerin (BCG) could be
an important adjunct to control, which would require a diagnostic test to differenti-
ate Mycobacterium bovis (M. bovis)-infected and BCG-vaccinated animals (DIVA role).
This study describes an evaluation of a DIVA skin test (DST) that is based on a cocktail
(DSTc) or fusion (DSTf) of specific (ESAT-6, CFP-10 and Rv3615c)M. bovis proteins in
Zebu–Holstein–Friesians crossbred cattle in Ethiopia. The study animals usedwere 74
calves (35 BCG vaccinated and 39 unvaccinated) aged less than 3 weeks at the start
of experiment and 68 naturally infected ‘TB reactor’ cows. Six weeks after vaccination,
the 74 calves were tested with the DSTc and the single intradermal cervical compara-
tive tuberculin (SICCT) test. The TB reactor cows were tested with the DSTc and the
SICCT test. Reactions to the DSTc were not observed in BCG-vaccinated and unvac-
cinated calves, while SICCT test reactions were detected in vaccinated calves. DSTc
Abbreviations: BCG, Bacillus Calmette–Guerin; BTB, bovine tuberculosis; CFP-10, culture filtrate protein 10 kDa; DIVA, differentiate infected from vaccinated; DST, DIVA skin test; DSTc, cocktail
protein-based DST; DSTf, fusion protein-based DST; ESAT-6, early secretory antigen target 6 kDa; LMICs, low- andmiddle-income countries; PPD-A, avian purified protein derivative; PPD-B,
bovine purified protein derivative; RD1, region of difference 1; SICCT, single intradermal cervical comparative tuberculin; SIT, single intradermal tuberculin
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reactionswere detected in 95.6% of the TB reactor cows and single intradermal tuber-
culin positive reactionswere found in 98.2% (95%confidence interval, CI, 92.1–100%).
The sensitivity of theDSTcwas95.6% (95%CI, 87.6–99.1%), and significantly (p< .001)
higher than the sensitivity (75%,95%CI, 63.0–84.7%)of theSICCT test at 4mmcut-off.
DSTf andDSTc reactionswere correlated (r=0.75; 95%CI=0.53–0.88). In conclusion,
the DSTc could differentiateM. bovis-infected from BCG-vaccinated cattle in Ethiopia.
DSThadhigher sensitivity than theSICCT test.Hence, theDSTccouldbeusedasadiag-
nostic tool for bTB if BCGvaccination is implemented for the control of bTB in Ethiopia
and other countries.
KEYWORDS
BCG vaccination, bovine tuberculosis, crossbred cattle, DIVA skin test, specific mycobacterial
proteins
1 INTRODUCTION
In Ethiopia, intensive dairy farms that raise genetically improved dairy
cows have been established around cities and towns (Ameni et al.,
2018; Mekonnen et al., 2019) to address national nutritional needs.
The development of the dairy sector has been constrained by the
emergenceof diseases associatedwith intensification, includingbovine
tuberculosis (bTB) (Ameni et al., 2007; Firdissa et al., 2012). bTB is
an endemic disease in Ethiopia (reviewed by Sibhat et al., 2017) and
the disease is affecting livestock production through reduction of pro-
ductivity and trade restrictions (OIE, 2018; Tschopp et al., 2012). As a
zoonotic disease, bTB poses a public health threat, especially in low-
and middle-income countries (LMICs) like in Ethiopia (Ashford et al.,
2001).
Many developed countries have controlled bTB in their livestock
populations using detection and slaughter of reactor animals (Buddle
et al., 2013; Schiller et al., 2010). However, in many LMICs, the imple-
mentation of such control is economically and societally unacceptable
and different control strategies need to be considered. Vaccination is
an alternative control strategy and BCG is the only currently avail-
able vaccine. Research trials evaluating the efficacy of BCG vaccina-
tion against M. bovis infection in cattle have demonstrated promising
results (Vordermeier et al., 2009;Ameni et al., 2010;Ameni et al., 2018;
Vordermeier et al., 2016a ; reviewed by Buddle et al., 2018). However,
BCG vaccination sensitizes vaccinated animals to react to tuberculin-
based tests, such as single intradermal cervical comparative tuberculin
(SICCT) or single intradermal tuberculin (SIT) tests (Vordermeier et al.,
2001;Whelan et al., 2010) as BCGwas originally derived fromM. bovis,
compromising their specificity. The current standard for diagnosis of
TB in cattle measures cell-mediated immune response to intradermal
injection of tuberculin. The SIT test is performed by injecting 0.1 ml of
3000 IU of bovine purified tuberculin (PPD-B) into the skin of the mid-
cervical region or in the base of the tail, while the SICCT test entails
simultaneous injection of both PPD-B and avian PPD (PPD-A) side-by-
side into the skin of the neck for discriminating animals infected with
M. bovis and those sensitized with M. avium complex or environmen-
tal non-tuberculous mycobacteria (reviewed by de la Rua-Domenech
et al., 2006). However, both PPD-B and PPD-A are poorly defined anti-
gens resulting in suboptimal sensitivity and inconsistent performance
(Bezos et al., 2014; Buddle et al., 2009; Schiller et al., 2010). Therefore,
there is a need for a diagnostic test that differentiatesM. bovis infected
fromBCG-vaccinated animals (DIVA role).
Significant progress has been made applying defined antigens as
DIVA tests for cattle (Jones et al., 2012; Srinivasan et al., 2019; Vor-
dermeier et al., 1999; Vordermeier et al., 2002; Vordermeier et al.,
2011;Vordermeier et al., 2016b), usingmycobacterial antigens present
in field strains of M. bovis but absent in the BCG vaccine. These anti-
gens include early secretory antigen target-6 kDa (ESAT-6) and culture
filtrate protein-10 kDa (CFP-10) (Pollock & Anderson, 1997; Vorder-
meier et al., 1999; Vordermeier et al., 2001). Their encoding genes are
located within the region of difference 1 (RD1) of theM. bovis genome,
a region was deleted from all BCG strains (Garnier et al., 2003; Gor-
don et al., 1999). As a result, T-cells of the BCG-vaccinated and/or non-
infected cattle do not recognize ESAT-6 and CFP-10. However, the use
of the cocktail of these two antigens showed a lower capacity in detect-
ing infected animals compared with tuberculin-based tests (Sidders
et al., 2008;Vordermeier et al., 2011). In attempts to overcome this lim-
itation, the antigen Rv3615c was discovered to be a useful additional
DIVA antigen to complement ESAT-6 andCFP-10 (Sidders et al., 2008).
This protein cocktail of Rv3615c, ESAT-6 and CFP-10 has previ-
ously been evaluated as a blood and skin test reagent, mainly in Bos
taurus breeds, such as Holstein–Friesians (Casal et al., 2012; Vorder-
meier et al., 2016b) but not in zebu cattle or cross-breeds between
zebus and taurine cattle. In the present study, the protein cocktail-
based DIVA skin test (DSTc), as well as a fusion protein (DSTf) of the
same antigens, were evaluated in Zebu–Holstein–Friesian crossbreed
cattle under field condition.
2 MATERIALS AND METHODS
2.1 Study animals and husbandry
The studywas conducted onHolstein-Friesian x Zebu crossbred calves
and cows. The calves were all male and recruited from bTB free dairy
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farms within 2 weeks of age. Upon arrival at our animal facility, the
calves were screened by the whole blood interferon-gamma release
assay (IGRA) to demonstrate freedom from infection (data not shown).
The cows (herein known as TB reactors) were recruited from a bTB-
positive herd and tested positive for bTB upon recruitment by both
IGRA and SICCT. The naïve calves and the TB reactor cows were kept
in separate barns at theNational AnimalHealthDiagnostic and Investi-
gation Center at the Sebeta, Ethiopia. The calves were fed on pasteur-
ized partially skimmedmilk, hay and concentrate. The TB reactor cows
were fed on hay and concentrate. Both the calves and the TB reactor
cowswere watered ad libitum.
2.2 Study design, plan and setting
This is a cross-sectional study in which the performance of the DSTc
was evaluated in comparison with the SIT and SICCT tests. First, the
diagnostic specificity of DSTc was tested on 74 calves. The calves were
randomly assigned into BCG vaccinated and control groups using a lot-
tery method. Accordingly, 35 calves were vaccinated subcutaneously
by 1 x 106 CFU of BCG Sofia (InterVax Ltd, Toronto, ON, Canada)
at 2 weeks of age, while the remaining 39 were kept unvaccinated.
Relative low dose of 104–106 CFU has demonstrated to be effica-
cies in inducing protective immunity (Vordermeier et al., 2016b). After
6weeks post-vaccination, both the vaccinated andunvaccinated calves
were tested by theDSTc and SICCT tests. The sensitivity was tested on
68 TB reactor cows using both theDSTc and SICCT tests. In addition to
the DSTc, an additional study was undertaken to assess the diagnostic
performance of the recombinant fusion protein of ESAT-6, CFP-10 and
Rv3615c as a DIVA skin test (DSTf). After 12 months of the previous
trial, only 30 of the 68 TB reactor cows were left as the other 38 were
culled due to shortage of logistics of keeping them for a longer time.
Hence, these30TB reactor cowswereused for comparisonof theDSTf
with the DSTc and SICCT test; they were tested simultaneously with
intradermal injection of DSTf and DSTc on one side of the neck, while
SICCTwas applied on the other side of the neck of the study animals.
2.3 Antigens
The cocktail protein-based DST (DSTc) consisted of the ESAT-6,
CFP-10 and Rv3615c antigens of M. tuberculosis and M. bovis. The
individual recombinant proteins were produced by Lionex GmbH,
Braunschweig, Germany. Briefly, histidine-tagged recombinant pro-
teins were expressed in Escherichia coli (E. coli), purified by nickel
affinity chromatography, re-folded against 10 mM NH4HCO3 (pH 8.0)
and lyophilized. Western blots demonstrated a positive reaction when
using anti-histidine tag and/or protein-specific antibodies, and no reac-
tion with anti-E. coli antibody. Purity was assessed at> 95% using SDS-
PAGE and densitometry. When preparing the DSTc, equal amounts of
each freeze-dried protein were combined in a PBS solution containing
100 μg/ml of each protein (300 μg total protein/ml). The DSTc solution
was stored at−80◦C until needed. The DSTf reagent was produced by
Lionex following the sameapproach,with the exception that itwas sup-
plied as solution (300μg total protein/ml) after buffer exchange against
phosphate buffered saline (PBS; pH 7.4) and stored at 4◦C until being
used.
2.4 Protein-based DIVA skin test
All study animals (BCG vaccinated and control calves; bTB-positive
cows)were injected intradermallywith 0.1mlDSTc (30μg total protein
per dose) into the middle of the right side of the neck. For the compar-
ison between the DSTc and DSTf, 0.1 ml DSTc (30 μg protein per dose)
was injected 10 cmbelow the crest and 0.1mlDSTfwas injected 12 cm
below DSTc on a vertical line. Skin thicknesses were measured before
inoculation and at 72 h post inoculation. Themeasurementswere done
by the same operator using the same digital caliper in every testing.
Results are expressed as the difference in skin-fold thickness (in mil-
limetre) before administration of the antigens and 72 h post admin-
istration. Skin reaction was considered positive if the increase in skin
thickness at the DSTc or DSTf site was greater than or equal to 2 mm
(Casal et al., 2012; Vordermeier et al., 2016b).
2.5 Single intradermal cervical comparative
tuberculin test
The SICCT test was performed on the left side of the study ani-
mals in the middle of the neck. After preparation of the injection site,
0.1 ml PPD-A (3000IU/ml; Prionics, Lelystad, The Netherlands) was
inoculated 10 cm below the crest and the same volume of PPD-B
(2500IU/ml; Prionics) was injected at a site 12 cm apart from PPD-A
injection site in vertical line in reactor cows. The skin thicknesses were
measured just before injection and at 72 h post injection by the same
operator using the same digital caliper, and the results were presented
as change in skin thickness (mm) between the two readings. In case of
the SIT test, skin reaction was defined as positive when the increase of
skin thickness at PPD-B site was greater than or equal to 4 mm, other-
wise considered as negative. For the SICCT test, the differences in the
increase of skin thickness at the bovine and avian PPD injection sites
were considered. An animal was considered to be positive when the
increase in skin thickness at the bovine PPD site was greater than the
increase in skin thickness at the site of the avian injection by at least
4 mm. If the differential increases between the two sites were equal to
or less than 1 mm, or between 1 and 4 mm, the animal was considered
negative or doubtful, respectively (OIE, 2018).
2.6 Data analysis
Data analysis was performed using Prism 8 (GraphPad Software). The
skin-fold thickness increase was summarized using median and 95%
confidence interval of median (95% CI) after assessment of normality
of the data.Wilcoxonmatched-pair signed rank test was performed for
comparison of skin reactions induced by two defined antigens while
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F IGURE 1 Skin thickness in response to DSTc, PPD-B, PPD-A and PPD-(B-A) in 35 BCG-vaccinated calves (Panel a), in 39 non-vaccinated
naïve calves (Panel b) and in 68 naturally infected reactor cattle (Panel c). Individual animal skin thickness change (millimetre) between the pre-
and post-skin test readings was represented by solid squares for DSTc, open circles for PPD (B-A), solid triangles for PPD-B and solid circles for
PPD-Awith a horizontal line providing themedian change of respective defined antigen. The statistical difference in skin reaction was determined
using non-parametric Friedman test with Dunn’s multiple comparison test. There was a significant difference (p< .001) betweenDSTc and
tuberculin in causing skin reaction in the BCG-vaccinated calves, while similar skin reaction (p> .05) was developed following inoculation of all
defined antigens in naïve calves. Significantly (p< .001) stronger skin response in naturally infected reactor cattle was also developed following
PPD-B intradermal injection compared to the outcome of DSTc. The dashed horizontal lines at 2 and 4mm are the cut-offs used for DSTc, and
PPD-(B-A) and PPD-B, respectively
using the Friedman test (repeated measures non-parametric analysis
of variance) with Dunn’s multiple comparison test for more than two
defined antigens. In addition, Spearman rank test was used for evalu-
ation of the correlation of the degree of skin thickness induced by dif-
ferent antigens. A comparison of theDSTc relative sensitivitywas scru-
tinized using the Fisher’s exact test. Kappa test was made to evaluate
the diagnostic agreement between the DSTc and that of the SICCT or
SIT test. In all cases, a 95%CI and a significant level of 5%were used to
express statistical significance.
3 RESULTS
3.1 Performance of DSTc as a DIVA test in
vaccinated and unvaccinated calves
Six weeks post-vaccination, the BCG-vaccinated (n = 35) and unvac-
cinated control (n = 39) calves were skin tested with the DSTc and
avian and bovine PPD (PPD-A, PPD-B) (Data S1). All BCG vaccinated
calves were DSTc negative (Figure 1a, median of increase in skin thick-
ness: 0.40 mm, 95% CI = 0.05−0.89). In contrast, all of the vaccinated
calves responded to PPD-B and were SIT positive (Figure 1a, median
reaction sizes PPD-B: 10.91 mm, 95% CI= 8.50−13.67). Furthermore,
82.9% (95%CI= 65.7−92.4) of the vaccinated calves were positive for
the SICCT test (Figure 1a, median PPD-B minus PPD-A: 6.60 mm, 95%
CI = 4.87−7.85). Comparative analysis indicated that the skin thick-
ness induced by DSTc in calves was significantly lower than the skin
thickness induced either by PPD-B (p < .001) or by PPD-A (p < .001).
These data demonstrated the superior specificity of DSTc compared
to SIT or SICCT. Therefore, the DSTc demonstrated its DIVA utility
in crossbred cattle in Ethiopia. As observed with the BCG-vaccinated
calves, none of the unvaccinated calves showed a skin reaction differ-
enceof2mmorhigher and theywere, therefore, classified asDSTcneg-
ative (Figure 1b; median reaction size: 0.72 mm, 95% CI = 0.33−0.99).
Similarly, none of the unvaccinated calves were positive either in the
SIT (median reaction size 0.64 mm, 95% CI= 0.30−0.90) or the SICCT
test (median reaction size: 0.57mm, 95%CI= 0.32–0.85; Figure 1b).
3.2 Diagnostic performance of DSTc in
bTB-infected cows
The diagnostic sensitivity of the DSTc was tested in 68 naturally
infected TB reactor cows from a confirmed bTB-positive herd (Data
S1). The recordedmedian of skin thickness increasewas 6.25mm (95%
CI= 5.30−6.76) at the DSTc injection site, while themedian skin thick-
nesses were 10.82 mm (95% CI = 9.55−13.63) at PPD-B and 4.48 mm
(95% CI = 3.59–5.03) at PPD-A sites. The result indicated that the
median increase of skin thickness to DSTc injection was significantly
lower (p < .001) than the median in skin thickness at the injection site
of PPD-B (Figure 1c). On the other hand, by considering the SICCT
results, the median of the differences in skin thickness at the injec-
tion site of PPD-B and the injection site at PPD-A was 7.10 mm (95%
CI = 5.54−8.40), which did not statistically (p > .05) differ from the
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TABLE 1 Comparison of the diagnostic performance of the cocktail protein-based DIVA skin test (DSTc) with the performances of the single
intradermal tuberculin (SIT) test and the single comparative cervical tuberculin (SICCT) test in detecting bTB infection






DSTc 65 3 95.6 (87.6–99.1%)
SIT test 67 1 98.5 (92.1–100%)
SICCT test 51 17 75.0 (63.0–84.7%)
Evaluation of test agreements in 107 cattle with different status of bTB
SIT test SICCT test
Positive Negative Positive Doubtful Negative
DSTc Positive 65 0 51 10 4
Negative 2 40 0 1 41
Total 67 40 51 11 45
Fischer’s exact p value .000 .000
Tests agreement (k) 0.96 0.74
Bold values indicate p< 0.001.
median skin thickness at the injection site of DSTc. Thus, there was no
difference in thicknesses induced by the DSTc and SICCT tests.
As summarized in Table 1, out of 68 animals, 65 were positive to the
DSTc, resulting in a relative sensitivity of 95.6% (95%CI=86.9–98.6%).
Similarly, the relative sensitivity of SIT was 98.2% (67/68 animals posi-
tive, 95%CI=89.83–99.80). On the other hand, only 51 of the 68 reac-
torswere identified as positive by the SICCT test and hence, its relative
sensitivity was 75.0% (95%CI = 63.1–84.1%). As a result, the relative
sensitivity of the SICCT testwas significantly (p< .001) lower than that
of DSTc.
The diagnostic agreement of the DSTc and the SIT test as well as
that of theDSTc and the SICCT testwas evaluated on 107 cattle (68 TB
reactor cowsand39calves).Outof those cattle, 65wereDSTc-positive,
while the remaining 42 were negative for the DSTc test (Table 1). The
test agreement of the DSTc with the SIT and SICCT tests was 98.13%
and 85.98%, respectively. Thus, a strong agreement (k= 0.96, p< .001)
was recorded between the DSTc and SIT tests, while moderate agree-
ment (k = 0.74, p < .001) was recorded between the DSTc and SICCT
tests.
3.3 Diagnostic performance of the DST fusion
protein in reactor cattle
Thediagnostic performanceof theDSTfwasevaluated in30TBreactor
cows. The reactivity of the skin to injection with DSTf was compared
with the skin reactivity after injection with DSTc, PPD-B and PPD-A.
The results of this experiment are presented in Figure 2. The median
of skin thickness increases at the DSTf injection site was 5.89 mm
(95% CI = 5.43−7.08) compared to 5.38 mm (IQR = 4.53−8.85) at
the DSTc site. The medians of skin thicknesses were 6.32 mm (95%
CI = 5.52−7.25) at the PPD-A site and 9.97 mm (IQR = 8.35−13.03)
F IGURE 2 Comparison of skin reaction response of DSTf to the
response of PPD-A, PPD-B, PPD-(B-A) and that of DSTc in 30 naturally
infected cows. The skin-fold thickness wasmeasured before and after
72 h of injections. Results are shown as increases in skin thickness
(mm), which are represented by open square, solid square, open circle,
solid triangle and solid circle with horizontal lines providing the
median skin thickness change of respective antigen. PPD-B induced
significantly stronger skin reaction (p< .001) than that caused by DSTf
using the Friedman test (repeatedmeasures non-parametric analysis
of variance) with Dunn’s multiple comparison tests. There was no
significant difference (p> .05) between the responses induced by
DSTf andDSTc in reactor cattle. The dashed horizontal lines at 2 and
4mm are the cut-offs used for DSTf and DSTc, and PPD (B-A) and
PPD-B, respectively
6 BAYISSA ET AL.
F IGURE 3 Correlation of skin reaction responses between the
DSTf (dose 30 μg) and the DSTc (dose 10 μg per protein). Solid black
circle represents an individual study animal. The dashed horizontal
and vertical lines at 2 and 4mm are the cut-offs used for DSTc and
DSTf, respectively
at the PPD-B site. Multiple comparison analysis revealed that the skin
thickness caused by DSTf inoculation was statistically lower (p < .001)
than that caused by PPD-B inoculation (Figure 2). On the other hand,
the thickness caused by inoculation of DSTf was similar to the dif-
ference in skin thicknesses of the PPD-B site and PPD-A site (Fig-
ure 2, median difference between PPD-B and PPD-A readings was
3.55 mm, IQR = 3.34−5.39). Likewise, there was no significant dif-
ference (p > .05) in skin thicknesses caused by inoculation of DSTf
and DSTc (Figure 2). A statistically, a strong correlation (r = 0.753;
95%CI = 0.532−0.879; p < .001) was recorded between the DSTf and
DSTc as demonstrated in Figure 3.
4 DISCUSSION
The present study was conducted to evaluate the performance of a
DIVA skin test (DST), based on the M. tuberculosis complex proteins
ESAT-6, CFP-10 and Rv3615c using either a cocktail (DSTc) or a fusion
protein (DSTf), in differentiatingM. bovis-infected andBCG-vaccinated
cattle. The study was conducted on 74 non-infected calves, and 68 TB
reactor cows from herd with confirmed bTB prevalence, and all cattle
were Zebu–Holstein–Friesian crossbreed. The calves consisted of two
groups, that is 35 BCG-vaccinates and 39 non-vaccinates. The results
of theDSTcwere analysed and evaluated for its performance as aDIVA
skin test. Furthermore, the performance of the DSTc was compared
with that of the SIT andSICCT tests in 68TB reactor cows. Suchevalua-
tion of DIVA reagents has repeatedly been performed in taurine breed
cattle in developed countries settings (Casal et al., 2012; Jones et al.,
2012; Vordermeier et al., 2016a;Whelan et al., 2010 , b). However, this
is the first study toevaluate theDSTcandDSTfproteins in zebu-taurine
crossbred cattle in the context of developing countries; hitherto, only a
peptide cocktail of these antigens has been tested in TB reactor cattle
in Ethiopia (Srinivasan et al., 2019).
The relative specificity of theDSTcwas evaluated in 35non-infected
and BCG-vaccinated calves, which were recruited from known bTB
free dairy herds and also re-affirmed to be free of bTB by IGRA. Six
weeks after subcutaneous inoculation with 1x106 CFU dose of BCG,
they did not react to intradermal injection of the DSTc, giving a rela-
tive specificity of 100% (95% CI = 90.0–100). Similar to the present
result, previous studies reported that antigenic protein- or peptide-
based intradermal DSTc did not induce detectable skin reactions in
BCG-vaccinated taurine cattle (Jones et al., 2012; Vordermeier et al.,
2016b;Whelan et al., 2010). Similarly, all the 39 non-vaccinated calves
did not react to all the three (DSTc, SIT and SICCT) tests and the speci-
ficity of DSTc in non-vaccinated calves was 100%. Furthermore, DSTc
detected 65 of the 68 TB reactor cows, while the SICCT test detected
51 of them. Thus, the sensitivity of the DSTc was 95.6%, while the sen-
sitivity of the SICCT test was 75%, suggesting theDSTc has higher sen-
sitivity than the SICCT test. Recently, Srinivasan et al. (2019) recorded
similar level of sensitivity of peptide cocktail-based DIVA skin test in
bTB-positive cattle in Ethiopia, although our sample size was substan-
tially larger. All recruited study animals were positive by the SIT aswell
as by the SICCT test during the evaluation trials. The sensitivity of the
DSTc in the present study was higher than the sensitivity of the DSTc
reported by other studies (Casal et al., 2012; Jones et al., 2012; Vorder-
meier et al., 2016a), here in crossbreed cattle, which encourages the
future application of DSTc in conjunction with BCG usage.
In addition to estimation of the sensitivity and specificity of the
DSTc, Kappa statistics was used to evaluate its agreement with the SIT
and SICCT tests. The agreement between the DSTc and SIT tests was
strong, while on the other hand, a moderate agreement was recorded
between the DSTc and SICCT tests. In another field evaluation, a mod-
erate agreement was recorded between the DSTc and SIT tests in 23
reactors (Casal et al., 2012). However, since the true disease status
of the test animals was not known, it is difficult to make a conclusive
remark on the sensitivities and specificities of DSTc unless a gold stan-
dard test (TB lesion and orM. bovis isolation) is used. Therefore, there
is a need for further evaluation of the sensitivities and specificities of
DSTc on a large number of cattle using the appropriate gold standard
test.
With regard to the intensity of the skin thickness induced by the
injection of the DSTc, the magnitude of skin thickness induced by DSTc
and PPD-B was compared in TB reactor cows and it was observed that
the median of skin thickness induced by DSTc injection (6.3 mm) was
lower than those inducedbyPPD-B (10.8mm). This observationagreed
with the observations made earlier by other studies elsewhere in tau-
rine cattle (Jones et al., 2012; Srinivasan et al., 2019; Whelan et al.,
2010). The stronger skin reaction to PPD-B could be because it con-
sists of a more diverse range of immunogenic proteins (Borsuk et al.,
2009), whereas the DSTc contains only the three mycobacterial pro-
teins ESAT-6, CFP-10 and Rv3615c. Moreover, a dose of tuberculin
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solution contains greater protein content than adoseof theDSTc (Yang
et al., 2013). The strong skin reaction following PPD-B could also be
due to less purification compared to the highly purified DSTc. Except
Casal et al. (2012), who recorded comparablemedians skin thicknesses
by injection of DSTc and PPD-B, other researchers recommended the
possibility of strengthening the skin reaction toDSTcbyaddingRv3020
(Jones et al., 2012; Vordermeier et al., 2016b).
Inmost of the earlier studies, the experiments evaluatingDIVA tests
were conducted onwhole blood-based IFN-γ assays for easiness of the
protocol to accommodate modifications (Vordermeier et al., 2016b).
However, the use of these DIVA reagents in the IFN-γ assay will be dif-
ficult to implement in areas with economic and technical constraints
(Ameni et al., 2000). In contrast, theDIVA skin testing is a simpler tech-
nique and can easily be applied in the field in the sameway as the tuber-
culin skin test. Thus, a recombinant fusion protein containing ESAT-6,
CFP-10 and Rv3615-c (DSTf) was produced in a similar presentation
as PPD-B, containing 1.2 ml (12 doses) per vial. In the present field
trial in reactor cattle, the DSTc and DSTf demonstrated comparable
medians of skin thickness in 30 TB reactor cows. Like DSTc, the DSTf
induced skin reaction equivalent to the final skin thickness induced by
the SICCT test. Therefore, these observations encourage the use of
DSTc or DSTf for the diagnosis of bTB in cattle.
5 CONCLUSION
This is the first study to investigate the performance of the DIVA skin
test based on a cocktail/fusion protein of threemycobacterial antigens
(ESAT-6, CFP-10 and Rv3615c) in zebu-taurine crossbred cattle. The
data showedhigh sensitivity of theDSTc in TB reactor cows and its high
specificity in BCG-vaccinated bTB free calves after 6 weeks of BCG
vaccination. The data generated by the twoDST preparations (cocktail
and fusion) were comparable. Thus, the findings of this study demon-
strated the potential utility of DSTc or DSTf to support BCG vaccine-
based bTB control policies, although additional extended field evalua-
tion of these tests is important for re-affirmation of the observations of
this study.
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